title: Androgen receptor splice variant V7 (AR-V7) in circulating tumor cells: a coming of age for AR splice variants?
authors.affiliation: Department of Medicine, University of Washington, Seattle, USA.
authors.forename: C
authors.initials: C
authors.lastname: Sprenger
authors.affiliation: Department of Medicine, University of Washington, Seattle, USA.
authors.forename: T
authors.initials: T
authors.lastname: Uo
authors.affiliation: Department of Medicine, University of Washington, Seattle, USA. Electronic address: splymate@u.washington.edu.
authors.forename: S
authors.initials: S
authors.lastname: Plymate
mesh_terms: D000736:Androstenes / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001549:Benzamides; D014408:Biomarkers, Tumor / Q000235:genetics*; D006801:Humans; D008297:Male; D009364:Neoplasm Recurrence, Local / Q000235:genetics / Q000473:pathology; D009360:Neoplastic Cells, Circulating / Q000473:pathology*; D009570:Nitriles; D010669:Phenylthiohydantoin / Q000031:analogs & derivatives / Q000627:therapeutic use; D011471:Prostatic Neoplasms / Q000188:drug therapy* / Q000235:genetics* / Q000473:pathology; D020033:Protein Isoforms / Q000235:genetics; D011944:Receptors, Androgen / Q000235:genetics*; D016896:Treatment Outcome
chemical_list: C410798:AR protein, human; D000736:Androstenes; D000970:Antineoplastic Agents; D001549:Benzamides; D014408:Biomarkers, Tumor; D009570:Nitriles; D020033:Protein Isoforms; D011944:Receptors, Androgen; D010669:Phenylthiohydantoin; C540278:enzalutamide; C089740:abiraterone